A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma

Archives of Dermatology

Volumn 137, Issue 3, 2001, Pages 325-330

  Tsao, H ^a   Nadiminti, U ^a   Sober, A J ^a   Bigby, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOPHENOL MONOOXYGENASE;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE MARKER; HUMAN; MELANOMA; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; NEOPLASM CIRCULATING CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035076048     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. PSA screening for prostate cancer: The current controversy - A viewpoint
2. PSA screening for prostate cancer: The current controversy
3. Screening for prostate cancer
4. PSA screening: Current controversy
5. Cancer statistics, 2000
6. Prognostic clinical and pathological features
7. Diagnosis and treatment of metastatic melanoma
8. Tyrosinase activity in the serum of patients with malignant melanoma
9. Tyrosinase gene expression in human tissues
10. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
11. Simultaneous analysis of tyrosinase mRNA and markers of tyrosinase activity in the blood of patients with metastatic melanoma
12. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients
13. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression
14. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma
15. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: Evaluation strategy and correlation with known prognostic markers in 123 melanoma patients
16. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients
17. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study
18. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis
19. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression
20. Detection of tyrosinase mRNA from the blood of melanoma patients
21. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma
22. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction
23. Detection of tyrosinase mRNA in melanoma by reverse transcription-PCR and electrochemiluminescence
24. Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine-needle aspirates
25. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma
26. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma
27. Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma
28. Detection of tumor messenger RNA in the serum of patients with malignant melanoma
29. The detection of circulating melanoma cells correlates with tumour thickness and ulceration but is hot predictive of metastasis for patients with primary melanoma
30. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases
31. Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma
32. Hematogenous spread of malignant melanoma cells in different stages of disease
33. Cancer statistics, 1999
34. The detection of tyrosinase-specific mRNA in bone marrow is not more sensitive than in blood for the demonstration of micrometastatic melanoma
35. Blood
36. An improved and combined reverse transcription-polymerase chain reaction assay for reliable detection of metastatic melanoma cells in peripheral blood
37. Detection and quantitation of melanoma cells in the circulation of patients
38. A polymerase chain reaction-based semi-quantitative assessment of malignant melanoma cells in peripheral blood
39. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
40. Melanoma-associated antigens as messenger RNA detection markers for melanoma
41. Serum S100: A marker for disease monitoring in metastatic melanoma
42. Elevated serum levels of S100 and survival in metastatic malignant melanoma
43. S-100 protein in peripheral blood: A marker for melanoma metastases: A prospective 2-center study of 570 patients with melanoma